Provides analysis of the World Health Organization’s (WHO) draft Road Map for Access to Medicines, Vaccines and Other Health Products including an overview of the contents and the potential implications if approved. This roadmap, which outlines WHO’s proposed workplan on access for the period 2019–2023, will be presented to the WHO Executive Board in January 2018 for input and then will go before the World Health Assembly in May for endorsement.
Letter to the Office of Management and Budget (OMB), detailing the role of US agencies in global health R&D and recommending funding levels for
Provides an overview of the opportunities and institutions GHTC targets in the multilateral arena, why GHTC advocates in that arena, and how our members and partners can participate in these opportunities.
Provides background on the Global Health Security Agenda (GHSA) and limitations with its current structure, and offers recommendations to expand the comprehensiveness of the program in advancing global health security through the adoption of a new action package on global health R&D.
